Furthermore, in prion infected animals, gene therapy to deliver eIF2α phosphatase [157], oral treatment with an inhibitor of PERK [158] and treatment with ISRIB [159], a compound that blocks the consequences of p-eIF2α, provided neuroprotection, attenuated disease progression and protected against prion disease. The gene discussed is EIF2AK3; the disease is prion disease.